Activities of pefloxacin and ciprofloxacin in experimentally induced Pseudomonas pneumonia in neutropenic guinea pigs
Open Access
- 1 April 1985
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 27 (4), 452-454
- https://doi.org/10.1128/aac.27.4.452
Abstract
Pefloxacin and ciprofloxacin are two new quinoline carboxylic acid derivatives that have activity in vitro against a wide range of gram-negative bacteria, including Pseudomonas aeruginosa. Using a well-standardized model of Pseudomonas pneumonia in neutropenic guinea pigs, we tested the efficacy in vivo of these new agents. Both were highly effective in increasing survival and decreasing bacterial counts in the lungs of surviving animals. Pefloxacin and ciprofloxacin were significantly better (P less than 0.05) than aminoglycosides or beta-lactams tested in prior studies with this model, and they were as effective as combination therapy with aminoglycosides and beta-lactams. Resistance to either ciprofloxacin or pefloxacin did not emerge during the study period. Further studies with these drugs in the therapy of Pseudomonas sp. infections are warranted.This publication has 12 references indexed in Scilit:
- Comparative activities of ciprofloxacin, ticarcillin, and tobramycin against experimental Pseudomonas aeruginosa pneumoniaAntimicrobial Agents and Chemotherapy, 1984
- Single Versus Combination Antibiotic Therapy for Pneumonia Due to Pseudomonas aeruginosa in Neutropenic Guinea PigsThe Journal of Infectious Diseases, 1984
- In vitro activity of ciprofloxacin compared with those of other new fluorinated piperazinyl-substituted quinoline derivativesAntimicrobial Agents and Chemotherapy, 1984
- Absorption, distribution, metabolic fate, and elimination of pefloxacin mesylate in mice, rats, dogs, monkeys, and humansAntimicrobial Agents and Chemotherapy, 1984
- In-vitro studies with ciprofloxacin, a new 4-quinolone compoundJournal of Antimicrobial Chemotherapy, 1984
- Ciprofloxacin, a quinolone carboxylic acid compound active against aerobic and anaerobic bacteriaAntimicrobial Agents and Chemotherapy, 1984
- Pharmacokinetics and tissue penetration of ciprofloxacinAntimicrobial Agents and Chemotherapy, 1983
- In vitro activity of ciprofloxacin (Bay o 9867)Antimicrobial Agents and Chemotherapy, 1983
- In vitro activity of Bay 09867, a new quinoline derivative, compared with those of other antimicrobial agentsAntimicrobial Agents and Chemotherapy, 1983
- Aerobic gram-negative bacillary pneumonias.Published by Elsevier BV ,1974